MARKET

HOOK

HOOK

Hookipa Pharma Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

12.50
+0.09
+0.73%
Opening 11:06 01/29 EST
OPEN
12.41
PREV CLOSE
12.41
HIGH
13.29
LOW
12.41
VOLUME
5.63K
TURNOVER
--
52 WEEK HIGH
14.76
52 WEEK LOW
6.06
MARKET CAP
325.94M
P/E (TTM)
-34.0414
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of HOOK and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 5 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

HOOK News

  • 2 Small-Cap Biotech Stocks to Watch in 2020
  • MotleyFool.com.6d ago
  • Is HOOKIPA Pharma (NASDAQ:HOOK) Using Debt In A Risky Way?
  • Simply Wall St..01/15 14:53
  • Hookipa Pharma up 2% on advancement of Gilead partnership
  • seekingalpha.01/06 20:49
  • HOOKIPAs Gilead Sciences Collaboration for HIV and HBV Therapeutic Vaccines Advancing Towards Clinical Entry
  • GlobeNewswire.01/06 12:00

More

Industry

Pharmaceuticals
+0.50%
Pharmaceuticals & Medical Research
+0.39%

Hot Stocks

Name
Price
%Change

About HOOK

HOOKIPA Pharma Inc. is a clinical-stage biopharmaceutical company. The Company is developing products to prevent and cure infectious diseases and cancer. The Company's infectious and oncology product candidates HB-101, HB-201 and HB-202. The infectious disease product candidate, HB-101, is in a randomized, double-blinded Phase II clinical trial in cytomegalovirus-negative patients awaiting kidney transplantation from cytomegalovirus-positive donors. Its lead oncology product candidates, HB-201 and HB-202, are in development for the treatment of human papillomavirus-positive cancers. The Company offers VaxWave technology, which is designed to induce a robust CD8+ T cell and pathogen neutralizing response to fight disease. VaxWave technology supports the benefits of our arenavirus platform approach.
More

Webull offers Hookipa Pharma Inc (HOOK) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.